• Drives the clinical development strategy for the assigned compound(s) across the medicine lifecycle, from proof of concept to successful global regulatory approval(s)/market access for multiple treatment indications. • Provides clinical and scientific expertise to set and execute the asset strategy and optimize project success. • Works with functional members, TA head and CAT Leaders to develop Integrated Project Plans (IPP) documents. • Identifies risks for the program with other functions and develops mitigation strategies to address them. • Presents the nephrology clinical program to internal (including the CEO and the Executive Committee of the Organisation) and external stakeholders (Health Authorities, Steering Committees, Independent Data Monitoring Committees, and Patient Organisations etc), engages when necessary with Key Opinion Leaders across geographies. • Is a core member of the benefit risk team (BRT), of regulatory submission teams and of the labeling working group. • Ensures endorsement of clinical development plans and study documents by Sobi governance bodies (e.g. Sobi Evidence Generation Board, Study Document Review Forum). • Leads in a matrix the clinical scientists and the Medicine Development Team (consists of representatives from Medical Affairs, Clinical Science, Regulatory, Safety/PV, non-clinical/PK, Biostatistics/Data management, Clinical Program Management, Heath Economics and Outcome Research, RWE, Program Management), providing strategic guidance and being the ultimate accountable for: Clinical trial design (clinical study synopsis and protocol development), planning (e.g. sites and countries selection), execution (e.g.medical monitoring, resolution of safety issues; interpretation of statistical analyses) and internal and external communication of study results • Creation of clinical components of key documents (Clinical Development Plans, Clinical Study Protocols, Investigator’s Brochures, Clinical Study Reports, regulatory documents including maintenance of product licenses, Clinical Modules of registration dossiers, Briefing Books for interactions with Health Authorities) with high quality and consistency with the Integrated Project Plan and Target Product Profile. • Provision of required input on clinical efficacy, safety, dosing/administration, mechanism of action, etc for the Target Product Profile (TPP) Support to registration and market access (Core Data Sheet, Development Safety Update Report, Periodic Safety Update Report, clinical benefit-risk assessment) o Collaboration with Regulatory team to determine international submission strategy.

• Lead and develop a team of Cost Managers and the delivery of cost management services. • Ensure service excellence in terms of service delivery and client engagement. • Conduct research related to construction market conditions. • Produce thought leadership reports providing insights to the construction market. • Manage financial aspects of cost management and support business growth.

• The Director, Global Services, Eastern Region is responsible for the overall success of a portfolio of REMAX Canada franchisees (Broker/Owners) and their respective agents. • This role serves as the primary point of contact, relationship manager, and liaison between franchisees and REMAX Canada. • The Director plays a critical role in driving organic agent growth, operational efficiencies and profitability, and retention for franchisees by identifying owner/manager needs and creating tailored support and service plans. • Leveraging internal resources to deliver operational, financial, and organizational guidance and consultative support. • Supporting the execution of the Region Development department’s growth strategy, including achieving net agent count in territory through organic recruitment and retention strategies and collaboration with Global Sales team on conversions and M&A. • Increasing adoption of brand tools and programs (Aspire, MaaS, RaaS, MaxEngage, REIC Verification, etc.) and driving and upholding brand image and identity with franchisees in their portfolio (exterior signage, websites, yard signs, etc.). • Proactively working with franchisees and REMAX corporate on renewals and accounts receivable. • Utilizing REMAX consultative methodology such as internal Momentum program to provide operational and consultative support.

• Develop and lead U.S. market access strategies aligned with brand and portfolio objectives across a 3+ year horizon. • Define value proposition and access roadmap from pre-launch through lifecycle management. • Shape and implement integrated evidence plans, in partnership with HEOR and Medical Affairs to support access and payer negotiations • Serve as the enterprise subject matter expert on access, payer dynamics, and policy trends across the landscape and within specialty and rare disease • Oversee development of AMCP dossiers, payer communication tools (including Pre-approval Information Exchange and Payer Value Proposition) and field access tools (including product coverage, prior authorization criteria and patient support options). • Guide economic modeling and budget impact analyses to support payer discussions • Collaborate and partner closely with Commercial to align access strategy with brand strategy. • Engage with Government Affairs on policy implications and advocacy priorities. • Represent the organization in external advisory boards and industry forums. • Monitor payer landscape, competitive dynamics, and regulatory changes to inform strategy. • Lead, coach, and develop high-performing Market Access professionals. • Select and retain agency partners, holding full budget authority for access strategies • Drive cross-functional alignment in matrixed environments.